tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Climb Bio Challenges Alumis Milestone and Royalty Obligations
PremiumCompany AnnouncementsClimb Bio Challenges Alumis Milestone and Royalty Obligations
2M ago
Climb Bio initiated with a Buy at Freedom Capital
Premium
The Fly
Climb Bio initiated with a Buy at Freedom Capital
2M ago
Climb Bio price target raised to $11 from $9 at H.C. Wainwright
Premium
The Fly
Climb Bio price target raised to $11 from $9 at H.C. Wainwright
2M ago
Climb Bio’s Promising ITP Study: A Potential Game-Changer for Investors
PremiumCompany AnnouncementsClimb Bio’s Promising ITP Study: A Potential Game-Changer for Investors
4M ago
Climb Bio’s Promising Phase 1b Study on Budoprutug for Lupus: A Market Game-Changer?
Premium
Company Announcements
Climb Bio’s Promising Phase 1b Study on Budoprutug for Lupus: A Market Game-Changer?
4M ago
Climb Bio’s Phase 2 Study on Budoprutug: A Potential Game-Changer in Nephrology
Premium
Company Announcements
Climb Bio’s Phase 2 Study on Budoprutug: A Potential Game-Changer in Nephrology
4M ago
Climb Bio initiated with an Outperform at William Blair
PremiumThe FlyClimb Bio initiated with an Outperform at William Blair
4M ago
Climb Bio initiated with a Buy at H.C. Wainwright
Premium
The Fly
Climb Bio initiated with a Buy at H.C. Wainwright
4M ago
Climb Bio management to meet virtually with BTIG
Premium
The Fly
Climb Bio management to meet virtually with BTIG
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100